Regulation of SIRT1-TLR2/TLR4 pathway in cell communication from macrophages to hepatic stellate cells contribute to alleviates hepatic fibrosis by Luteoloside
- 16 December 2022
- journal article
- research article
- Published by Elsevier in Acta Histochemica
- Vol. 125 (1) , 151989
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- TLR2/4 ligand-amplified liver inflammation promotes initiation of autoimmune hepatitis due to sustained IL-6/IL-12/IL-4/IL-25 expressionMolecular Immunology, 2018
- Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targetsHepatobiliary & Pancreatic Diseases International, 2018
- Baicalein ameliorates TNBS-induced colitis by suppressing TLR4/MyD88 signaling cascade and NLRP3 inflammasome activation in miceScientific Reports, 2017
- Limiting inflammation—the negative regulation of NF-κB and the NLRP3 inflammasomeNature Immunology, 2017
- NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in miceJournal of Hepatology, 2017
- Emerging roles of SIRT1 in fatty liver diseasesInternational Journal of Biological Sciences, 2017
- Eclipta prostrata L. phytochemicals: Isolation, structure elucidation, and their antitumor activityFood and Chemical Toxicology, 2012
- TLR4 enhances TGF-β signaling and hepatic fibrosisNature Medicine, 2007
- Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1Nature, 2005
- The Role of Interleukin 1 Receptor-associated Kinase-4 (IRAK-4) Kinase Activity in IRAK-4-mediated SignalingJournal of Biological Chemistry, 2004